Stock VPA AVEO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Delayed Börse Stuttgart
Other stock markets
 15:33:53 05/10/2021 BST 		5-day change 1st Jan Change
5.28 EUR -0.19% Intraday chart for AVEO Pharmaceuticals, Inc. -10.02% +20.93%
03-25 AVEO Pharmaceuticals, Inc. Announces Executive Changes CI
02-06 Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
AVEO Pharmaceuticals, Inc. Announces Executive Changes
CI
Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist
CI
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
CI
AVEO Oncology Announces Completion of Enrollment in Pivotal Phase 3 TiNivo-2 Study of FOTIVDA(R) in Combination with OPDIVO(R) in Advanced Renal Cell Carcinoma
CI
South Korean Stocks Climb on Demand Recovery Hopes from China; LG Chem Stocks Add 1%
MT
AVEO Completes Acquisition by LG Chem
MT
LG Chem Acquires US Biopharma Firm AVEO Pharmaceuticals
MT
AVEO PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
LG Chem Completes Acquisition of AVEO Oncology
GL
AVEO Pharmaceuticals, Inc. Announces Management Changes
CI
AVEO Oncology Appoints Martin Birkhofer as Its Chief Medical Officer
CI
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from NASDAQ Composite Index
CI
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P Global BMI Index
CI
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P TMI Index
CI
LG Chem, Ltd. completed the acquisition of AVEO Pharmaceuticals, Inc. from a group of shareholders.
CI
AVEO Pharmaceuticals Receives CFIUS Clearance for LG Chem Merger
MT
AVEO Pharmaceuticals : Merger Agreement - Form 8-K
PU
AVEO PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
AVEO Pharmaceuticals Stockholders Approve LG Chem Merger
MT
AVEO Oncology Stockholders Approve Acquisition by LG Chem
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVEO Stock
  4. VPA Stock
  5. News AVEO Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW